FIELD: biotechnology.SUBSTANCE: present invention refers to biotechnology. Disclosed are compositions and systems containing vectors comprising polynucleotide sequences coding components of CRISPR-Cas type II complex, as well as a kit containing one of such compositions or systems.EFFECT: present invention enables the change of genomic loci of the eukaryotic cell by using Cas9 nuclease fused with one or more nuclear localization sequences (NLS).25 cl, 74 dwg, 16 ex